Clinicians only - cpms CPMS

facebook

twitter

youtube

linkedin

Home - News - The Hidden Costs of Rare Diseases, a feasibility study

December 01 2016

The Hidden Costs of Rare Diseases, a feasibility study

SHARE

Genetik Alliance UK has conducted a study on the hidden costs of Rare Diseases, assessing how best to measure and evaluate the true costs of managing rare conditions.

More info here

Read the full report here

Vascular Anomalies (VASCA-WG) CPMS case discussions continue 1

23 November 2023

Vascular Anomalies (VASCA-WG) CPMS case discussions continue

Countdown to Rare Disease Day 2024

21 November 2023

Countdown to Rare Disease Day 2024

Deadline Extended: Apply Now for the 1st Edition of VASCERN Summer School on Rare Vascular Diseases 1

15 November 2023

Deadline Extended: Apply Now for the 1st Edition of VASCERN Summer School on Rare Vascular Diseases

The Rare disease community unites in an open letter for continued support of European Reference Networks

10 November 2023

European Commission Calls for Patient Organization Representatives in EMA’s Committee for Orphan Medicinal Products

Exciting Interim Results from Phase III Trial VASE: Sirolimus Shows Promise in Managing Vascular Malformations

08 November 2023

Exciting Interim Results from Phase III Trial VASE: Sirolimus Shows Promise in Managing Vascular Malformations

06 November 2023

New ERN Information Brochure for 2023

Exciting Interim Results from Phase III Trial VASE: Sirolimus Shows Promise in Managing Vascular Malformations

06 November 2023

New Research Unveils the Complex Role of TGFβ Signaling in Thoracic Aortic Aneurysm and Dissection

Discover Our New Heritable Thoracic Aortic Diseases E-Learning Course 1

20 October 2023

Discover Our New Heritable Thoracic Aortic Diseases E-Learning Course

IMG_20231005_123153_auto_x2_light_ai

16 October 2023

Reflecting on VASCERN Days 2023: Two days of collaboration & knowledge exchange